Serina Therapeutics Inc. Company Profile
NYSE: SERHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Serina Therapeutics at a glance
Serina Therapeutics Inc. (NYSE: SER) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Huntsville, AL. Serina Therapeutics is led by Mr. Steven A. Ledger and employs about 16 people. The company's shares have traded publicly since 2018.
At a market capitalization of $51.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001708599, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Serina Therapeutics do?
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. It has a partnership agreement with Gannet BioChem to support development activities for SER-252. Serina Therapeutics, Inc. was founded in 2006 and is headquartered in Huntsville, Alabama.
Business description based on the company's public filings.
Company information
- Legal name
- Serina Therapeutics Inc.
- Ticker
- NYSE: SER
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Steven A. Ledger
- Employees
- 16
- Headquarters
- 601 Genome Way, Huntsville, AL, United States
- Phone
- 256 327 9630
- Website
- serinatherapeutics.com
- IPO year
- 2018
- Market cap
- $51.05M
- SEC CIK
- 0001708599
Companies similar to Serina Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HYPDHyperion DeFi Inc. | 3.37 | -6.27% | $51.16M | vs SER |
| ANVSAnnovis Bio Inc. | 1.17 | -3.31% | $49.93M | vs SER |
| CRVOCervoMed Inc. | 3.28 | +3.14% | $49.59M | vs SER |
| EDSAEdesa Biotech Inc. | 3.66 | -5.79% | $49.45M | vs SER |
| ACETAdicet Bio Inc. | 5.74 | -7.12% | $53.73M | vs SER |
| DWTXDogwood Therapeutics Inc. | 1.41 | -1.40% | $47.93M | vs SER |
| ZYBTZhengye Biotechnology Holding Limited Class A | 1.15 | -0.87% | $54.50M | vs SER |
| ELTXElicio Therapeutics Inc. | 1.81 | -2.16% | $47.57M | vs SER |